Principal Investigator
Hadar Lev-Tov
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20250001
Clinical Trial Summary
An open-label, single-arm study to evaluate the pharmacokinetics and safety of subcutaneous sonelokimab in adolescents aged 12 to ≤17 years at the time of study inclusion with active moderate to severe hidradenitis suppurativa
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other